Related Experiment Video
Updated: Jan 30, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Systemic multipotent adult progenitor cells improve long-term neurodevelopmental outcomes after preterm
Melinda Barkhuizen1, Ralph van Mechelen2, Marijne Vermeer2
1Department of Pediatrics, Maastricht University Medical Center (MUMC), Maastricht, the Netherlands; Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNs), Maastricht University, Maastricht, the Netherlands; DST/NWU Preclinical Drug Development Platform, North-West University, Potchefstroom, South Africa.
Insights
Multipotent adult progenitor cells (MAPCs) show promise in treating preterm hypoxic-ischemic encephalopathy. MAPC therapy partially improved long-term behavioral outcomes in a rat model, suggesting potential therapeutic benefits.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Perinatal Medicine
Background:
- Preterm hypoxic-ischemic encephalopathy (HIE) poses a significant disease burden.
- There is an urgent need for effective therapeutic interventions for HIE.
- Current treatments for HIE have limitations in addressing long-term neurodevelopmental deficits.
Purpose of the Study:
- To evaluate the long-term behavioral effects of multipotent adult progenitor cells (MAPCs) in a preterm rat model of perinatal asphyxia.
- To investigate the efficacy of MAPC therapy in mitigating locomotor, cognitive, and psychiatric impairments following HIE.
- To determine if MAPC treatment influences sex-dependent outcomes in HIE.
Main Methods:
- A preterm rat model of perinatal asphyxia was established.
- Rats received two doses of MAPCs within 24 hours post-insult.
- Locomotor activity, object recognition memory, and anxiety-like behaviors were assessed at juvenile (1.5 months) and adult (6 months) stages.
- Sex-specific effects of HIE and MAPC treatment were analyzed.
Main Results:
- Hypoxia-ischemia induced sex-dependent impairments in locomotion, cognition, and anxiety, with males showing higher vulnerability.
- MAPC therapy partially improved object recognition memory in females across all ages and in adult males.
- MAPC treatment corrected delayed hyperactivity observed in adult males post-hypoxic insult.
Conclusions:
- MAPC therapy demonstrates potential for long-term neurodevelopmental benefits following preterm birth and global hypoxia-ischemia.
- The findings suggest MAPCs may partially ameliorate cognitive and behavioral deficits in HIE.
- Further preclinical research is warranted to explore the therapeutic potential of MAPCs for HIE.
Abstract:
There is an urgent need for therapies that could reduce the disease burden of preterm hypoxic-ischemic encephalopathy. Here, we evaluate the long-term effects of multipotent adult progenitor cells (MAPC) on long-term behavioral outcomes in a preterm rat model of perinatal asphyxia. Rats of both sexes were treated with two doses of MAPCs within 24 h after the insult. Locomotor, cognitive and psychiatric impairments were evaluated starting at 1.5 (juvenile) and 6 months (adult). Hypoxia-ischemia affected locomotion, cognition, and anxiety in a sex-dependent manner, with higher vulnerability observed in males. The MAPC therapy partially attenuated deficits in object recognition memory in females of all tested ages, and in the adult males. The hypoxic insult caused delayed hyperactivity in adult males, which was corrected by MAPC therapy. These results suggest that MAPCs may have long-term benefits for neurodevelopmental outcome after preterm birth and global hypoxia-ischemia, which warrants further preclinical exploration.
Related Concept Videos
Adult Stem Cells
Multipotency of Hematopoietic Stem Cells
Multipotency and Niche of Bulge Stem Cell
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Predicting Reaction Outcomes
Long-term Depression

